Tadataka Yamada, MD

SENIOR ADVISOR

Dr. Tadataka (Tachi) Yamada is a Venture Partner with Frazier Healthcare Partners. As a member of the Frazier Life Sciences team he focuses on creating companies as well as providing strategic guidance to existing portfolio companies. He chairs the boards of Phathom Pharmaceuticals and Passage Bio and serves as Director of a number of private life science companies. Prior to joining Frazier Dr. Yamada was Executive Vice-President, Chief Medical & Scientific Officer and a Board Member of Takeda Pharmaceuticals. Dr. Yamada has also served as President of the Bill & Melinda Gates Foundation Global Health Program. He was formerly Chairman, Research and Development and a Member of the Board of Directors of GlaxoSmithKline and before that he was Chair of the Department of Internal Medicine and Physician-in-Chief at the University of Michigan Medical Center.

Dr. Yamada holds a bachelor’s degree in history from Stanford University and obtained his M.D. from New York University School of Medicine. In recognition of his contributions to medicine and science he has been elected to membership in the National Academy of Medicine (US), the American Academy of Arts and Sciences, the Academy of Medical Sciences (UK) and the National Academy of Medicine (Mexico). He has been conferred an honorary appointment as Knight Commander of the Most Excellent Order of the British Empire (KBE), the Honorary Citizen Award from the Government of Singapore and the Order of the Rising Sun, Gold and Silver Stars from the Japanese Government. He is a Past-President of the Association of American Physicians and of the American Gastroenterological Association and he has served as a member of the President’s Council of Advisors on Science and Technology and the Advisory Committee to the Director of the National Institutes of Health. He was formerly Vice Chair of the Council of the National Academy of Medicine and currently serves as Chairman of the Board of Directors of the Clinton Health Access Initiative.